Table 3.
Peculiarities of benign tumors |
Total |
SCA |
MCA |
BCA |
AF |
Fibroma |
MT |
Gonadoblastoma |
SST |
Cysts |
Age [years] |
||||||||||
Prepuberty (0–9) |
15 |
2 (13%) |
1 (7%) |
0 (0%) |
0 (0%) |
0 (0%) |
6 (40%) |
0 (0%) |
0 (1%) |
6 (40%) |
Puberty (10–17) |
97 |
15 (15%) |
9 (9%) |
3 (3%) |
1 (1%) |
2 (2%) |
18 (19%) |
1 (1%) |
1 (1%) |
47 (49%) |
Sex |
||||||||||
Male |
7 |
2 (29%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
2 (29%) |
0 (0%) |
0 (0%) |
3 (43%) |
Female |
105 |
15 (14%) |
10 (10%) |
3 (3%) |
1 (1%) |
2 (2%) |
22 (21%) |
1 (1%) |
1 (1%) |
50 (48%) |
Size [cm] |
||||||||||
<5 |
27 |
8 (30%) |
3 (11%) |
1 (4%) |
0 (0%) |
0 (0%) |
3 (11%) |
0 (0%) |
0 (0%) |
12 (44%) |
5–10 |
63 |
6 (10%) |
5 (8%) |
1 (2%) |
1 (2%) |
0 (0%) |
19 (30%) |
0 (0%) |
0 (0%) |
31 (49%) |
>10 |
22 |
3 (14%) |
2 (9%) |
1 (5%) |
0 (0%) |
2 (9%) |
2 (9%) |
1 (5%) |
1 (5%) |
10 (45%) |
Tumor location |
||||||||||
Right |
47 |
10 (21%) |
4 (9%) |
2 (4%) |
0 (0%) |
2 (4%) |
7 (15%) |
0 (0%) |
0 (0%) |
22 (47%) |
Left |
55 |
6 (11%) |
5 (9%) |
1 (2%) |
1 (2%) |
0 (0%) |
16 (29%) |
0 (0%) |
1 (2%) |
25 (45%) |
Both sides |
10 |
1 (10%) |
1 (10%) |
0 (0%) |
0 (0%) |
0 (0%) |
1 (10%) |
1 (10%) |
0 (0%) |
6 (60%) |
Pain location |
||||||||||
Right |
31 |
7 (22.6%) |
3 (9.7%) |
0 (0%) |
0 (0%) |
1 (3.2%) |
6 (19.4%) |
0 (0%) |
0 (0%) |
12 (38.7%) |
Left |
56 |
7 (12.5%) |
7 (12.5%) |
1 (1.8%) |
0 (0%) |
0 (0%) |
15 (26.8%) |
0 (0%) |
1 (1.8%) |
28 (50%) |
Both sides |
20 |
2 (10%) |
0 (0%) |
2 (10%) |
1 (5%) |
1 (5%) |
2 (10%) |
0 (0%) |
0 (0%) |
11 (55%) |
Pain radiates to leg |
27 |
6 (22%) |
4 (15%) |
1 (4%) |
1 (4%) |
0 (0%) |
10 (37%) |
1 (4%) |
0 (0%) |
4 (15%) |
Repetition |
7 |
1 (14%) |
0 (0%) |
2 (29%) |
0 (0%) |
1 (14%) |
1 (14%) |
0 (0%) |
0 (0%) |
2 (29%) |
Prenatal diagnosis |
6 |
1 (17%) |
1 (17%) |
1 (17%) |
0 (0%) |
0 (0%) |
1 (17%) |
0 (0%) |
0 (0%) |
2 (33%) |
Gonadectomy |
27 |
5 (19%) |
2 (7%) |
2 (7%) |
1 (4%) |
0 (0%) |
9 (33%) |
0 (0%) |
0 (0%) |
8 (30%) |
Asymptomatic |
5 |
1 (20%) |
1 (20%) |
0 (0%) |
0 (0%) |
0 (0%) |
1 (20%) |
0 (0%) |
0 (0%) |
2 (40%) |
Appendicitis |
19 |
2 (11%) |
4 (21%) |
1 (5%) |
0 (0%) |
1 (5%) |
2 (11%) |
0 (0%) |
0 (0%) |
9 (47%) |
Loss of appetite |
19 |
9 (47%) |
5 (26%) |
2 (11%) |
1 (5%) |
0 (0%) |
1 (5%) |
0 (0%) |
0 (0%) |
1 (5%) |
Loss of weight |
5 |
2 (40%) |
1 (20%) |
2 (40%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
Leukocytosis |
35 |
9 (26%) |
3 (9%) |
1 (3%) |
1 (3%) |
1 (3%) |
5 (14%) |
0 (0%) |
0 (0%) |
15 (43%) |
Fever |
11 |
1 (9%) |
2 (18%) |
0 (0%) |
0 (0%) |
1 (9%) |
2 (18%) |
0 (0%) |
0 (0%) |
5 (45%) |
Constipation |
8 |
2 (25%) |
1 (13%) |
0 (0%) |
0 (0%) |
0 (0%) |
2 (25%) |
0 (0%) |
0 (0%) |
3 (38%) |
Vomit |
7 |
0 (0%) |
2 (29%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
5 (71%) |
Bleeding |
7 |
0 (0%) |
2 (29%) |
0 (0%) |
1 (14%) |
1 (14%) |
1 (14%) |
0 (0%) |
0 (0%) |
2 (29%) |
Abdominal distention |
24 |
2 (8%) |
1 (4%) |
1 (4%) |
0 (0%) |
2 (8%) |
9 (38%) |
1 (4%) |
1 (4%) |
7 (29%) |
Ascites |
4 |
1 (25%) |
1 (25%) |
0 (0%) |
0 (0%) |
0 (0%) |
1 (25%) |
0 (0%) |
0 (0%) |
1 (25%) |
GCT |
25 |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
24 (96%) |
1 (4%) |
0 (0%) |
0 (0%) |
Not GCT |
87 |
17 (20%) |
10 (11%) |
3 (3%) |
1 (1%) |
2 (2%) |
0 (0%) |
0 (0%) |
1 (1%) |
53 (61%) |
Loculation |
||||||||||
Unilocular cyst |
39 |
5 (13%) |
1 (3%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
33 (85%) |
Unilocular cyst + solid |
20 |
7 (35%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
4 (20%) |
1 (5%) |
0 (0%) |
8 (40%) |
Multilocular cyst |
28 |
2 (7%) |
9 (32%) |
0 (0%) |
1 (4%) |
1 (4%) |
5 (18%) |
0 (0%) |
0 (0%) |
10 (36%) |
Multilocular cyst + solid |
21 |
3 (14%) |
0 (0%) |
1 (5%) |
0 (0%) |
1 (5%) |
13 (62%) |
0 (0%) |
1 (5%) |
2 (10%) |
Multilocular solid |
4 |
0 (0%) |
0 (0%) |
2 (50%) |
0 (0%) |
0 (0%) |
2 (50%) |
0 (0%) |
0 (0%) |
0 (0%) |
Solid |
0 |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
Compressed organs |
16 |
6 (38%) |
2 (13%) |
1 (6%) |
0 (0%) |
0 (0%) |
1 (6%) |
0 (0%) |
0 (0%) |
6 (38%) |
Viruses |
6 |
2 (33%) |
0 (0%) |
0 (0%) |
0 (0%) |
0 (0%) |
2 (33%) |
0 (0%) |
1 (17%) |
1 (17%) |
Elevated tumor markers |
8 |
1 (13%) |
1 (13%) |
2 (25%) |
0 (0%) |
0 (0%) |
3 (38%) |
0 (0%) |
0 (0%) |
1 (13%) |
AF: Adenofibroma; BCA: Borderline cystadenoma; GCT: Germ cell tumor; MCA: Mucinous cystadenoma; MT: Mature teratoma; n: No. of cases; SCA: Serous cystadenoma; SST: Sclerosing stromal tumor.